|
|
Research |
|
Research Interest 1. Developing novel analytical methods for studying drug interactions -
Develop and establish novel analytical methods based on MS, such as ESI-MS,MALDI-MS and ICP-MS, to study the interaction between antitumor compounds and biological targets. -
Develop and establish secondary ion mass spectrometric imaging method to study the cellular uptake, distribution and destination of anticancer drugs inside cells. 2. Development of new methods and a new system for in-situ liquid secondary ion mass spectrometry -
Develop new methology of in situ and real-time liquid secondary ion mass spectrometry (SIMS) by interfacing SIMS with a high vacuum compatible microfluidic device; -
Application of in-situ liquid SIMS as an in-situ "molecular eye" to perform in-situ real-time analysis on various liquid surfaces or solid-liquid interfaces (electrode-electrolyte interface, heterogeneous catalytic reaction, bio-soft material interface such as cell membrane); -
Develop a new instrumental system of in-situ liquid SIMS with high-quality mass resolution and expand its application. 3. Research and development of multi-targeted anticancer drugs -
Design and synthesis multi-targeted metal complexes targeting both key signal transduction proteins and DNA; -
In vitro and in vivo screening and evaluation of metal-based anti-tumour compounds; -
The structure-activity study of metal-based anti-tumour compounds; -
The pharmacological, toxicological, pharmacokinetic and metabolic studies of metal-based anti-tumour drugs; 4. Chemical biology study based on multi-functional molecular probes -
Design and develop multi-functional small-molecular probes that can recognize both specific signal transduction proteins and DNA; -
Study the interaction between the multi-functional molecular probes and the biological targets to explore the cellular signalling pathways and networks; -
Study the interactions between the multi-functional molecular probes and receptors and their regulation to the signal transduction network to discover and pharmacologically valuable and clinically promising lead compounds. -
Applying the multi-functional molecular probes to screen and identify biomarkers and drugable targets; Current Research Projects -
2020.1 – 2024.12, NSFC National Major Research Project on Scientific Instruments:High resolution in situ liquid SIMS system (21927804),8 million CNY -
2016.1 – 2019.12, NSFC General Project: Methodology for investigations on the molecular mechanisms of metal antitumor drugs on the basis of chemical genetics (21575145), 0.78 million CNY |
|